◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Voyageur Pharmaceuticals Ltd.

VM.V TSXV Healthcare Calgary, Canada
Loading stock data...
Stock Performance
Price History
- Drag to select time range -
Market Data
Market Cap 28.6M
P/E Ratio -
52-Week High -
52-Week Low -
Avg Volume -
Beta -
Forward P/E -
Dividend Yield -
EV/Revenue -
Price/Book -
Business Overview

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer Aktiengesellschaft for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.

Healthcare Drug Manufacturers - Specialty & Generic TSXV
Key Financial Metrics
-
Revenue
-1.7M
Net Income
C$-0.01
EPS (Diluted)
-302,289
Free Cash Flow
Profitability
Gross Margin -
Operating Margin -
Net Profit Margin -
EBITDA -1.7M
Returns & Efficiency
Return on Assets (ROA) -65.7%
Return on Equity (ROE) -379.4%
Dividend Yield -
Payout Ratio -
Financial Health
Total Assets 2.6M
Total Debt 40,000
Debt to Equity 0.09x
Current Ratio 0.17
Company Info
IndustryDrug Manufacturers - Specialty & Generic
HQCalgary, Canada
Fiscal Year End1732924800
CurrencyCAD
Websitevoyageurpharmaceuticals.ca
Peers
7.9B
P/E: --
2.5B
P/E: 12.0
2.5B
P/E: 23.7
2.2B
P/E: 53.2
1.4B
P/E: 24.1
1.2B
P/E: --
1.1B
P/E: --
631.8M
P/E: --
Insider Activity
Sentiment Bullish
Shares Bought 1,152,250
Shares Sold 0
Total Transactions 3
SEDAR+ Filings
View All Filings
20
Quarterly Reports
19
MD&A
100
News Releases
32
Material Changes
12
Governance
43
Certifications
49
Other
Interactive Charts
Company Profile
General Information
Company NameVoyageur Pharmaceuticals Ltd.
TickerVM.V
ExchangeTSXV
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersCalgary, Canada
Fiscal Year End1732924800
CurrencyCAD
Websitevoyageurpharmaceuticals.ca
Financial Summary
Market Cap28.6M
RevenueN/A
Net Income-1.7M
P/E RatioN/A
EPS (Diluted)C$-0.01
Net MarginN/A
ROE-379.4%
Dividend YieldN/A
Business Description
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer Aktiengesellschaft for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
NEWS
Loading news...
TRENDING
Loading...